The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.
 
Xuezhu Cai
No Relationships to Disclose
 
Vyshak Chandra
No Relationships to Disclose
 
Yangming Ou
No Relationships to Disclose
 
Kyrre E. Emblem
Patents, Royalties, Other Intellectual Property - NordicNeuroLab AS,Bergen,Norway; NordicNeuroLab AS,Bergen,Norway (Inst)
 
Alona Muzikansky
No Relationships to Disclose
 
John Evans
No Relationships to Disclose
 
Jayashree Kalpathy-Cramer
No Relationships to Disclose
 
Jorg Dietrich
No Relationships to Disclose
 
Andrew S. Chi
No Relationships to Disclose
 
Patrick Y. Wen
Consulting or Advisory Role - Abbvie; Celldex; Genentech/Roche; Midatech Pharma; Momenta Pharmaceuticals; Novartis; Novocure; Sigma-Tau; Vascular Biogenics
Speakers' Bureau - Merck
Research Funding - Abbvie; Agios; Angiochem; AstraZeneca; Cubist; Exelixis; Genentech/Roche; GlaxoSmithKline; Karyopharm Therapeutics; Merck; Novartis; Sanofi; Vascular Biogenics
 
Bruce R. Rosen
No Relationships to Disclose
 
Tracy Batchelor
Honoraria - Advance Medical; Champions Biotechnology; Educational Concepts Group; Imedex; Oakstone Publishing; Research To Practice; Robert Michael Educational Institute; UpToDate
Consulting or Advisory Role - Agenus; Kirin Pharmaceuticals; Merck; Novartis; Proximagen; Roche/Genentech
Research Funding - AstraZeneca (Inst); Millennium (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Agenus; Kirin Pharmaceuticals; Merck; Novartis; Roche/Genentech
 
Elizabeth Robins Gerstner
No Relationships to Disclose